Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pieper

Showing results (111-120 of 247) with videos related to

Pageof 25
Sort By:
Circulation|June 3, 1997
Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I InvestigatorsS D Berkowitz, C B Granger, K S Pieper, et al.
European Heart Journal|October 17, 2006
The impact of anthropomorphic indices on clinical outcomes in patients with acute ST-elevation myocardial infarctionRajendra H Mehta, Robert M Califf, Jyotsna Garg, et al.
JAMA|February 12, 1998
Prognostic significance of the initial electrocardiogram in patients with acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary ArteriesW R Hathaway, E D Peterson, G S Wagner, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Prevalence, predictors, and impact of conservative medical management for patients with non-ST-segment elevation acute coronary syndromes who have angiographically documented significant coronary diseaseMark Y Chan, Kenneth W Mahaffey, Lena J Sun, et al.
The American Journal of Cardiology|November 15, 1988
Transient alterations of the QRS complex and ST segment during percutaneous transluminal balloon angioplasty of the left anterior descending coronary arteryN B Wagner, D C Sevilla, M W Krucoff, et al.
The American Journal of Cardiology|October 29, 2005
Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromesSunil V Rao, Kristi O'Grady, Karen S Pieper, et al.
Circulation. Cardiovascular Quality and Outcomes|February 18, 2010
Representation of women in randomized clinical trials of cardiovascular disease preventionChiara Melloni, Jeffrey S Berger, Tracy Y Wang, et al.
Archives of Internal Medicine|March 30, 2011
Age and outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: findings from the APEX-AMI trialS Michael Gharacholou, Renato D Lopes, Karen P Alexander, et al.
Journal of the American College of Cardiology|March 21, 1998
Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesC B Granger, R Becker, R P Tracy, et al.
Circulation. Cardiovascular Genetics|November 26, 2014
Simultaneous consideration of multiple candidate protein biomarkers for long-term risk for cardiovascular eventsSharif A Halim, Megan L Neely, Karen S Pieper, et al.
Pageof 25

Showing results (111-120 of 247) with videos related to

Sort By:
Pageof 25
Circulation|June 3, 1997
Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I InvestigatorsS D Berkowitz, C B Granger, K S Pieper, et al.
European Heart Journal|October 17, 2006
The impact of anthropomorphic indices on clinical outcomes in patients with acute ST-elevation myocardial infarctionRajendra H Mehta, Robert M Califf, Jyotsna Garg, et al.
JAMA|February 12, 1998
Prognostic significance of the initial electrocardiogram in patients with acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary ArteriesW R Hathaway, E D Peterson, G S Wagner, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Prevalence, predictors, and impact of conservative medical management for patients with non-ST-segment elevation acute coronary syndromes who have angiographically documented significant coronary diseaseMark Y Chan, Kenneth W Mahaffey, Lena J Sun, et al.
The American Journal of Cardiology|November 15, 1988
Transient alterations of the QRS complex and ST segment during percutaneous transluminal balloon angioplasty of the left anterior descending coronary arteryN B Wagner, D C Sevilla, M W Krucoff, et al.
The American Journal of Cardiology|October 29, 2005
Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromesSunil V Rao, Kristi O'Grady, Karen S Pieper, et al.
Circulation. Cardiovascular Quality and Outcomes|February 18, 2010
Representation of women in randomized clinical trials of cardiovascular disease preventionChiara Melloni, Jeffrey S Berger, Tracy Y Wang, et al.
Archives of Internal Medicine|March 30, 2011
Age and outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: findings from the APEX-AMI trialS Michael Gharacholou, Renato D Lopes, Karen P Alexander, et al.
Journal of the American College of Cardiology|March 21, 1998
Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesC B Granger, R Becker, R P Tracy, et al.
Circulation. Cardiovascular Genetics|November 26, 2014
Simultaneous consideration of multiple candidate protein biomarkers for long-term risk for cardiovascular eventsSharif A Halim, Megan L Neely, Karen S Pieper, et al.
Pageof 25